Healthcare Private Equity
SGP Holdings identifies, acquires, and builds operating businesses across healthtech, pharmaceutical manufacturing, CDMO and 505(b)(2) development, generics, specialty pharma, 503B outsourcing, and wholesale distribution — supporting each with capital, infrastructure, and hands-on operating leadership.
THE VALUE CHAIN WE OPERATE ACROSS
Our Approach
Our portfolio spans the full pharmaceutical value chain, from early-stage development and regulatory strategy through commercial-scale manufacturing and nationwide distribution. We partner with founders, operators, and management teams who bring deep clinical, regulatory, and commercial expertise, supporting them with the capital, infrastructure, and strategic guidance needed to scale sustainably within a highly regulated industry.
SGP Holdings takes a differentiated approach to healthcare investing. Rather than acting purely as a passive financial sponsor, we operate as a long-term, hands-on partner embedded in the businesses we support — working alongside leadership teams on regulatory compliance, supply chain strategy, manufacturing quality systems, and go-to-market execution.
The future of healthcare delivery depends on companies that innovate within regulatory frameworks — through 505(b)(2) pathways, compliant 503B infrastructure, and technology that improves patient access.
This embedded model lets us identify opportunities that purely financial investors often miss, and move quickly when disruption creates real opportunity.
Focus Areas
Technology platforms that improve patient access, adherence, and outcomes across the care journey.
Commercial-scale production infrastructure supporting our portfolio's branded and contract volume.
Development and manufacturing partnerships that carry client products from formulation to commercial supply.
Regulatory pathways that bring differentiated therapies to market faster, building on existing clinical data.
Cost-efficient production that expands access to essential medications at commercial scale.
Focused therapeutic programs requiring specialized manufacturing, handling, and commercial expertise.
Compliant outsourcing facilities providing compounded sterile preparations to hospitals and clinics nationwide.
Infrastructure connecting manufacturers to pharmacies, clinics, and health systems reliably and compliantly.
Contact
For partnership, acquisition, and portfolio inquiries, reach the SGP Holdings team directly.
info@sgpholdings.com